AMRI Closes Facility in NY - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

AMRI Closes Facility in NY



AMRI reported that it will be transitioning Discovery and Development Services (DDS) activities at its Syracuse, NY site to other sites within AMRI and will terminate all operations in Syracuse by the end of June 2014.

As part of the transition, Syracuse DDS capabilities and some employees will be transferred to other AMRI facilities, including Albany, NY; Cedarburg, Wis.; Holywell, UK; and Hyderabad, India. AMRI expects the closure will generate annual run-rate savings of approximately $1.5 million.

Source: AMRI

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
24%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
44%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here